F

Journal of Hematologic Oncology & Neuro-Lymphoma Research

An open-access journal publishing cutting-edge research in hematologic malignancies and central nervous system lymphoma.

4.2
Impact Factor
7.8
CiteScore
18 days
Avg. First Decision
2,840+
Published Articles

Latest Articles

Original Research

Venetoclax, Zanubrutinib, Selinexor, Glofitamab (IV + IT), Intrathecal Cytarabine, Obinutuzumab, and Involved-Field Radiation Therapy in Heavily Pretreated Secondary CNS DLBCL

Wei Jianming, Chen Lihua, Zhou Fang, Xu Mingzhi, Liu Yanhong
📄 12 citations👁 3,847 viewsSep 9, 2025
Original Research

Zanubrutinib-Containing Regimens in DLBCL and the Cerebrospinal Fluid Distribution of Zanubrutinib: A 13-Case Series

Zhang Y, Li Y, Zhuang Z, et al.
📄 66 citations👁 9,521 viewsAug 14, 2025
Review

Blood–Brain Barrier Penetration of Novel BTK Inhibitors: Implications for CNS Lymphoma Treatment

Chen F, Liu Y, Wang H, et al.
📄 89 citations👁 12,541 viewsJul 30, 2025
Case Report

Glofitamab Intrathecal Administration in Richter Transformation With Isolated CNS Relapse

Wang L, Xu Z, Song Y, et al.
📄 14 citations👁 3,218 viewsJul 21, 2025
Systematic Review

Efficacy and Safety of BTK Inhibitors in Central Nervous System Lymphoma: A Systematic Review and Meta-Analysis

Liu J, Huang D, Wu F, et al.
📄 78 citations👁 15,103 viewsJul 3, 2025
View all articles →

About this Journal

Publishing original research, reviews, and clinical reports on hematologic malignancies with emphasis on CNS involvement.

Learn more →

Sections

Pharmacology of Anti-Cancer Drugs Hematologic Malignancies Neuro-Oncology Immunotherapy & Biologics

Research Topics

CNS Penetration of Novel Agents Bispecific Antibodies in Lymphoma CAR-T in CNS Disease
Join Editorial Board